NCR3 and neoplasm: The NCRs expressed in Vδ1+ γδT cells (Figure 1), predominantly NKp44 and NKp30, endow these cells with heightened abilities for targeted cytotoxicity against tumor cells and for secreting IFN-γ (55, 61).